label,type,title,author,journal,abstract,year,doi,volume,issue,pages,language,issn,keywords,url,institution,DA,j2,DP,l1,l2,ST
Rocklov_2019_Emerinfedise,JOUR,"Using Big Data to Monitor the Introduction and Spread of Chikungunya, Europe, 2017","Rocklov, Joacim and Tozan, Yesim and Ramadona, Aditya and Sewe, Maquines O. and Sudre, Bertrand and Garrido, Jon and de Saint Lary, Chiara Bellegarde and Lohr, Wolfgang and Semenza, Jan C.",Emerging infectious diseases,"With regard to fully harvesting the potential of big data, public health lags behind other fields. To determine this potential, we applied big data (air passenger volume from international areas with active chikungunya transmission, Twitter data, and vectorial capacity estimates of Aedes albopictus mosquitoes) to the 2017 chikungunya outbreaks in Europe to assess the risks for virus transmission, virus importation, and short-range dispersion from the outbreak foci. We found that indicators based on voluminous and velocious data can help identify virus dispersion from outbreak foci and that vector abundance and vectorial capacity estimates can provide information on local climate suitability for mosquitoborne outbreaks. In contrast, more established indicators based on Wikipedia and Google Trends search strings were less timely. We found that a combination of novel and disparate datasets can be used in real time to prevent and control emerging and reemerging infectious diseases.",2019,10.3201/eid2506.180138,25,6,1041-1049,eng,1080-6059 1080-6040,"social media and data science and Humans and Europe and big data and Animals and Climate and Data Mining and History, 21st Century and Disease Outbreaks and Seasons and Public Health Surveillance and Population Dynamics and Geography, Medical and *Big Data and Europe/epidemiology and Aedes/virology and Mosquito Vectors/virology and *Chikungunya virus and Aedes albopictus and arbovirus and chikungunya and Chikungunya Fever/*epidemiology/history/*transmission/virology and Communicable Diseases, Emerging/epidemiology/history/transmission/virology and human mobility and vector-borne infections and vectorial capacity and viruses",NA,NA,2019/06//undefined,Emerg Infect Dis,NA,NA,NA,NA
Martinez.Bello_2019_Emerinfedise,JOUR,"Joint Estimation of Relative Risk for Dengue and Zika Infections, Colombia, 2015-2016","Martinez-Bello, Daniel Adyro and Lopez-Quilez, Antonio and Prieto, Alexander Torres",Emerging infectious diseases,"We jointly estimated relative risk for dengue and Zika virus disease (Zika) in Colombia, establishing the spatial association between them at the department and city levels for October 2015-December 2016. Cases of dengue and Zika were allocated to the 87 municipalities of 1 department and the 293 census sections of 1 city in Colombia. We fitted 8 hierarchical Bayesian Poisson joint models of relative risk for dengue and Zika, including area- and disease-specific random effects accounting for several spatial patterns of disease risk (clustered or uncorrelated heterogeneity) within and between both diseases. Most of the dengue and Zika high-risk municipalities varied in their risk distribution; those for Zika were in the northern part of the department and dengue in the southern to northeastern parts. At city level, spatially clustered patterns of dengue high-risk census sections indicated Zika high-risk areas. This information can be used to inform public health decision making.",2019,10.3201/eid2506.180392,25,6,1118-1126,eng,1080-6059 1080-6040,"Humans and Female and Male and Adolescent and Adult and Middle Aged and Young Adult and Child and Child, Preschool and Infant and Risk Assessment and Risk Factors and Colombia and Prevalence and Infant, Newborn and Bayes Theorem and Age Distribution and History, 21st Century and Geography, Medical and Zika Virus and viruses and Bayesian models and Colombia/epidemiology and conditional auto-regressive prior and dengue virus and Dengue Virus and Dengue/*epidemiology/history/virology and multivariate risk models and Risk maps and Zika virus and Zika Virus Infection/*epidemiology/history/virology",NA,NA,2019/06//undefined,Emerg Infect Dis,NA,NA,NA,NA
Spreco_2018_Emerinfedise,JOUR,"Evaluation of Nowcasting for Detecting and Predicting Local Influenza Epidemics, Sweden, 2009-2014","Spreco, Armin and Eriksson, Olle and Dahlstrom, Orjan and Cowling, Benjamin John and Timpka, Toomas",Emerging infectious diseases,"The growing availability of big data in healthcare and public health opens possibilities for infectious disease control in local settings. We prospectively evaluated a method for integrated local detection and prediction (nowcasting) of influenza epidemics over 5 years, using the total population in Ostergotland County, Sweden. We used routine health information system data on influenza-diagnosis cases and syndromic telenursing data for July 2009-June 2014 to evaluate epidemic detection, peak-timing prediction, and peak-intensity prediction. Detection performance was satisfactory throughout the period, except for the 2011-12 influenza A(H3N2) season, which followed a season with influenza B and pandemic influenza A(H1N1)pdm09 virus activity. Peak-timing prediction performance was satisfactory for the 4 influenza seasons but not the pandemic. Peak-intensity levels were correctly categorized for the pandemic and 2 of 4 influenza seasons. We recommend using versions of this method modified with regard to local use context for further evaluations using standard methods.",2018,10.3201/eid2410.171940,24,10,1868-1873,eng,1080-6059 1080-6040,"epidemiology and Epidemics and Humans and Sweden and surveillance and Population Surveillance and History, 21st Century and influenza and Sweden/epidemiology and infectious disease and viruses and evaluation research and human influenza and Influenza A Virus, H1N1 Subtype and Influenza A Virus, H3N2 Subtype and Influenza A virus/classification/genetics and Influenza, Human/*epidemiology/history/virology and nowcasting and signal detection analysis",NA,NA,2018/10//undefined,Emerg Infect Dis,NA,NA,NA,NA
Fecht_2020_Injoofep,JOUR,Advances in mapping population and demographic characteristics at small-area levels,"Fecht, Daniela and Cockings, Samantha and Hodgson, Susan and Piel, Frederic B. and Martin, David and Waller, Lance A.",International journal of epidemiology,"Temporally and spatially highly resolved information on population characteristics, including demographic profile (e.g. age and sex), ethnicity and socio-economic status (e.g. income, occupation, education), are essential for observational health studies at the small-area level. Time-relevant population data are critical as denominators for health statistics, analytics and epidemiology, to calculate rates or risks of disease. Demographic and socio-economic characteristics are key determinants of health and important confounders in the relationship between environmental contaminants and health. In many countries, census data have long been the source of small-area population denominators and confounder information. A strength of the traditional census model has been its careful design and high level of population coverage, allowing high-quality detailed data to be released for small areas periodically, e.g. every 10 years. The timeliness of data, however, becomes a challenge when temporally and spatially highly accurate annual (or even more frequent) data at high spatial resolution are needed, for example, for health surveillance and epidemiological studies. Additionally, the approach to collecting demographic population information is changing in the era of open and big data and may eventually evolve to using combinations of administrative and other data, supplemented by surveys. We discuss different approaches to address these challenges including (i) the US American Community Survey, a rolling sample of the US population census, (ii) the use of spatial analysis techniques to compile temporally and spatially high-resolution demographic data and (iii) the use of administrative and big data sources as proxies for demographic characteristics.",2020,10.1093/ije/dyz179,49 Suppl 1,Suppl 1,i15-i25,eng,1464-3685 0300-5771,United States and Population and Humans and Female and Male and Demography and big data and Social Class and Censuses and census and Spatial Analysis and administrative data and *Observational Studies as Topic and *Small-Area Analysis and spatio-temporal analysis,NA,NA,2020/04/01/,Int J Epidemiol,NA,NA,NA,NA
Zhu_2007_Joofclep,JOUR,The K-nearest neighbor algorithm predicted rehabilitation potential better than current Clinical Assessment Protocol,"Zhu, Mu and Chen, Wenhong and Hirdes, John P. and Stolee, Paul",Journal of clinical epidemiology,"OBJECTIVE: There may be great potential for using computer-modeling techniques and machine-learning algorithms in clinical decision making, if these can be shown to produce results superior to clinical protocols currently in use. We aim to explore the potential to use an automatic, data-driven, machine-learning algorithm in clinical decision making. STUDY DESIGN AND SETTING: Using a database containing comprehensive health assessment information (the interRAI-HC) on home care clients (N=24,724) from eight community-care regions in Ontario, Canada, we compare the performance of the K-nearest neighbor (KNN) algorithm and a Clinical Assessment Protocol (the ""ADLCAP"") currently used to predict rehabilitation potential. For our purposes, we define a patient as having rehabilitation potential if the patient had functional improvement or remained at home over a follow-up period of approximately 1 year. RESULTS: The KNN algorithm has a lower false positive rate in all but one of the eight regions in the sample, and lower false negative rates in all regions. Compared using likelihood ratio statistics, KNN is uniformly more informative than the ADLCAP. CONCLUSION: This article illustrates the potential for a machine-learning algorithm to enhance clinical decision making.",2007,10.1016/j.jclinepi.2007.06.001,60,10,1015-1021,eng,0895-4356,"Humans and Prognosis and Ontario and Artificial Intelligence and Computer Simulation and Activities of Daily Living and Diagnostic Errors and *Algorithms and Bayes Theorem and Patient Selection and Health Status Indicators and *Decision Making, Computer-Assisted and Home Care Services/organization & administration and Rehabilitation/*organization & administration",NA,NA,2007/10//undefined,J Clin Epidemiol,NA,NA,NA,NA
Cowling_2020_Joofclep,JOUR,A novel approach selected small sets of diagnosis codes with high prediction performance in large healthcare datasets,"Cowling, Thomas E. and Cromwell, David A. and Sharples, Linda D. and van der Meulen, Jan",Journal of clinical epidemiology,"OBJECTIVES: The objective of the study was to examine an approach for selecting small sets of diagnosis codes with high prediction performance in large datasets of electronic medical records. STUDY DESIGN AND SETTING: This was a modeling study using national hospital and mortality records for patients with myocardial infarction (n = 200,119), hip fracture (n = 169,646), or colorectal cancer surgery (n = 56,515) in England in 2015-2017. One-year mortality was predicted from ICD-10 codes recorded for at least 0.5% of patients using logistic regression ('full' models). An approximation method was used to select fewer codes that explained at least 95% of variation in full model predictions ('reduced' models). RESULTS: One-year mortality was 17.2% (34,520) after myocardial infarction, 27.2% (46,115) after hip fracture, and 9.3% (5,273) after colorectal surgery. Full models included 202, 257, and 209 ICD-10 codes in these populations. C-statistics for these models were 0.884 (95% confidence interval (CI) 0.882, 0.886), 0.798 (0.795, 0.800), and 0.810 (0.804, 0.817). Reduced models included 18, 33, and 41 codes and had c-statistics of 0.874 (95% CI 0.872, 0.876), 0.791 (0.788, 0.793), and 0.807 (0.801, 0.813). Performance was also similar when measured using Brier scores. All models were well calibrated. CONCLUSION: Our approach selected small sets of diagnosis codes that predicted patient outcomes comparably to large, comprehensive sets of codes.",2020,10.1016/j.jclinepi.2020.08.001,128,NA,20-28,eng,1878-5921 0895-4356,England and Humans and Electronic medical records and Big data and Prognosis and Comorbidity and International Classification of Diseases and Electronic Health Records/*standards and Multimorbidity and Colorectal Surgery/*statistics & numerical data and Datasets as Topic/*statistics & numerical data and Hip Fractures/diagnosis/*epidemiology and ICD-10 and International Classification of Diseases/*standards and Myocardial Infarction/diagnosis/*epidemiology and Statistical models and Variable selection,NA,NA,2020/12//undefined,J Clin Epidemiol,NA,NA,NA,NA
Westreich_2010_Joofclep,JOUR,"Propensity score estimation: neural networks, support vector machines, decision trees (CART), and meta-classifiers as alternatives to logistic regression","Westreich, Daniel and Lessler, Justin and Funk, Michele Jonsson",Journal of clinical epidemiology,"OBJECTIVE: Propensity scores for the analysis of observational data are typically estimated using logistic regression. Our objective in this review was to assess machine learning alternatives to logistic regression, which may accomplish the same goals but with fewer assumptions or greater accuracy. STUDY DESIGN AND SETTING: We identified alternative methods for propensity score estimation and/or classification from the public health, biostatistics, discrete mathematics, and computer science literature, and evaluated these algorithms for applicability to the problem of propensity score estimation, potential advantages over logistic regression, and ease of use. RESULTS: We identified four techniques as alternatives to logistic regression: neural networks, support vector machines, decision trees (classification and regression trees [CART]), and meta-classifiers (in particular, boosting). CONCLUSION: Although the assumptions of logistic regression are well understood, those assumptions are frequently ignored. All four alternatives have advantages and disadvantages compared with logistic regression. Boosting (meta-classifiers) and, to a lesser extent, decision trees (particularly CART), appear to be most promising for use in the context of propensity score analysis, but extensive simulation studies are needed to establish their utility in practice.",2010,10.1016/j.jclinepi.2009.11.020,63,8,826-833,eng,1878-5921 0895-4356,"Humans and Algorithms and Artificial Intelligence and Neural Networks, Computer and *Data Interpretation, Statistical and *Decision Trees and *Propensity Score and *Logistic Models",NA,NA,2010/08//undefined,J Clin Epidemiol,NA,NA,NA,NA
Hodgson_2020_Injoofep,JOUR,"Availability, access, analysis and dissemination of small-area data","Hodgson, Susan and Fecht, Daniela and Gulliver, John and Iyathooray Daby, Hima and Piel, Frederic B. and Yip, Fuyuen and Strosnider, Heather and Hansell, Anna and Elliott, Paul",International journal of epidemiology,"In this era of 'big data', there is growing recognition of the value of environmental, health, social and demographic data for research. Open government data initiatives are growing in number and in terms of content. Remote sensing data are finding widespread use in environmental research, including in low- and middle-income settings. While our ability to study environment and health associations across countries and continents grows, data protection rules and greater patient control over the use of their data present new challenges to using health data in research. Innovative tools that circumvent the need for the physical sharing of data by supporting non-disclosive sharing of information, or that permit spatial analysis without researchers needing access to underlying patient data can be used to support analyses while protecting data confidentiality. User-friendly visualizations, allowing small-area data to be seen and understood by non-expert audiences, are revolutionizing public and researcher interactions with data. The UK Small Area Health Statistics Unit's Environment and Health Atlas for England and Wales, and the US National Environmental Public Health Tracking Network offer good examples. Open data facilitates user-generated outputs, and 'mash-ups', and user-generated inputs from social media, mobile devices and wearable tech are new data streams that will find utility in future studies, and bring novel dimensions with respect to ethical use of small-area data.",2020,10.1093/ije/dyz051,49 Suppl 1,Suppl 1,i14-i4,eng,1464-3685 0300-5771,Public Health and England and Humans and Big Data and Confidentiality and open data and Wales and *Information Dissemination and *Access to Information and *Data Analysis and *Small-Area Analysis and environment and health and remote sensing and Small-area studies,NA,NA,2020/04/01/,Int J Epidemiol,NA,NA,NA,NA
Cuello.Garcia_2020_Joofclep,JOUR,Social media can have an impact on how we manage and investigate the COVID-19 pandemic,"Cuello-Garcia, Carlos and Perez-Gaxiola, Giordano and van Amelsvoort, Ludo",Journal of clinical epidemiology,"<e2><80><a2> In situations of emergencies and urgencies, such as the COVID-19 pandemic, many are disseminating information through social media channels; this has an impact on billions of persons worldwide. <e2><80><a2> Misinformation about the current pandemic occurs frequently in these platforms and can have serious consequences. <e2><80><a2> When properly used, social media can be a useful tool that provides opportunities to disseminate and receive relevant information for patients, clinicians, and scientists. <e2><80><a2> Better research methods and proper use of these platforms by health scientists and the public are warranted to address social media's role in health policy and individual decisions. A multidisciplinary approach with better outreach and dissemination is optimal.",2020,10.1016/j.jclinepi.2020.06.028,127,NA,198-201,eng,1878-5921 0895-4356,"COVID-19 and Humans and Big Data and Data Mining and *Social Media and Information Dissemination/*methods and Coronavirus Infections/*epidemiology and Pneumonia, Viral/*epidemiology and *Pandemics",NA,NA,2020/11//undefined,J Clin Epidemiol,NA,NA,NA,NA
Schmidt_2018_Joofclep,JOUR,Linear regression and the normality assumption,"Schmidt, Amand F. and Finan, Chris",Journal of clinical epidemiology,"OBJECTIVES: Researchers often perform arbitrary outcome transformations to fulfill the normality assumption of a linear regression model. This commentary explains and illustrates that in large data settings, such transformations are often unnecessary, and worse may bias model estimates. STUDY DESIGN AND SETTING: Linear regression assumptions are illustrated using simulated data and an empirical example on the relation between time since type 2 diabetes diagnosis and glycated hemoglobin levels. Simulation results were evaluated on coverage; i.e., the number of times the 95% confidence interval included the true slope coefficient. RESULTS: Although outcome transformations bias point estimates, violations of the normality assumption in linear regression analyses do not. The normality assumption is necessary to unbiasedly estimate standard errors, and hence confidence intervals and P-values. However, in large sample sizes (e.g., where the number of observations per variable is >10) violations of this normality assumption often do not noticeably impact results. Contrary to this, assumptions on, the parametric model, absence of extreme observations, homoscedasticity, and independency of the errors, remain influential even in large sample size settings. CONCLUSION: Given that modern healthcare research typically includes thousands of subjects focusing on the normality assumption is often unnecessary, does not guarantee valid results, and worse may bias estimates due to the practice of outcome transformations.",2018,10.1016/j.jclinepi.2017.12.006,98,NA,146-151,eng,1878-5921 0895-4356,Big data and Bias and *Linear Models and *Bias and *Sample Size and Epidemiological methods and Linear regression and Modeling assumptions and Statistical inference,NA,NA,2018/06//undefined,J Clin Epidemiol,NA,NA,NA,NA
Neumann_2016_Joofclep,JOUR,A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach,"Neumann, Ignacio and Santesso, Nancy and Akl, Elie A. and Rind, David M. and Vandvik, Per Olav and Alonso-Coello, Pablo and Agoritsas, Thomas and Mustafa, Reem A. and Alexander, Paul Elias and Schunemann, Holger and Guyatt, Gordon H.",Journal of clinical epidemiology,"An increasing number of organizations worldwide are using new and improved standards for developing trustworthy clinical guidelines. One of such approaches, developed by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) working group, offers systematic and transparent guidance in moving from evidence to recommendations. The GRADE strategy concentrates on four factors: the balance between benefits and harms, the certainty of the evidence, values and preferences, and resource considerations. However, it also considers issues around feasibility, equity, and acceptability of recommendations. GRADE distinguishes two types of recommendations: strong and weak. Strong recommendations reflect a clear preference for one alternative and should apply to all or almost all patients, obviating the need for a careful review of the evidence with each patient. Weak recommendations are appropriate when there is a close balance between desirable and undesirable consequences of alternative management strategies, uncertainty regarding the effects of the alternatives, uncertainty or variability in patients' values and preferences, or questionable cost-effectiveness. Weak recommendations usually require accessing the underlying evidence and a shared decision-making approach. Clinicians using GRADE recommendations should understand the meaning of the strength of the recommendation, be able to critically appraise the recommendation, and apply trustworthy recommendations according to their strength.",2016,10.1016/j.jclinepi.2015.11.017,72,NA,45-55,eng,1878-5921 0895-4356,"Decision making and Humans and Quality of Health Care and Female and Male and Decision Making and GRADE and Health Personnel/*education and Recommendations and Medical education and Evidence-based practice and Practice Guidelines as Topic/*standards and Clinical practice guidelines and Education, Medical/methods/*standards and Evidence-Based Medicine/*standards",NA,NA,2016/04//undefined,J Clin Epidemiol,NA,NA,NA,NA
Lanera_2018_Joofclep,JOUR,Extending PubMed searches to ClinicalTrials.gov through a machine learning approach for systematic reviews,"Lanera, Corrado and Minto, Clara and Sharma, Abhinav and Gregori, Dario and Berchialla, Paola and Baldi, Ileana",Journal of clinical epidemiology,"OBJECTIVES: Despite their essential role in collecting and organizing published medical literature, indexed search engines are unable to cover all relevant knowledge. Hence, current literature recommends the inclusion of clinical trial registries in systematic reviews (SRs). This study aims to provide an automated approach to extend a search on PubMed to the ClinicalTrials.gov database, relying on text mining and machine learning techniques. STUDY DESIGN AND SETTING: The procedure starts from a literature search on PubMed. Next, it considers the training of a classifier that can identify documents with a comparable word characterization in the ClinicalTrials.gov clinical trial repository. Fourteen SRs, covering a broad range of health conditions, are used as case studies for external validation. A cross-validated support-vector machine (SVM) model was used as the classifier. RESULTS: The sensitivity was 100% in all SRs except one (87.5%), and the specificity ranged from 97.2% to 99.9%. The ability of the instrument to distinguish on-topic from off-topic articles ranged from an area under the receiver operator characteristic curve of 93.4% to 99.9%. CONCLUSION: The proposed machine learning instrument has the potential to help researchers identify relevant studies in the SR process by reducing workload, without losing sensitivity and at a small price in terms of specificity.",2018,10.1016/j.jclinepi.2018.06.015,103,NA,22-30,eng,1878-5921 0895-4356,Machine learning and Humans and Meta-analysis and Clinical Trials as Topic and Text mining and Sensitivity and Specificity and Systematic review and Information Storage and Retrieval/methods and *Meta-Analysis as Topic and Search Engine/*methods and *Machine Learning and Data Mining/*methods and *Systematic Reviews as Topic and Clinical trial registry and Indexed search engine and PubMed/*organization & administration,NA,NA,2018/11//undefined,J Clin Epidemiol,NA,NA,NA,NA
Christodoulou_2019_Joofclep,JOUR,A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models,"Christodoulou, Evangelia and Ma, Jie and Collins, Gary S. and Steyerberg, Ewout W. and Verbakel, Jan Y. and Van Calster, Ben",Journal of clinical epidemiology,"OBJECTIVES: The objective of this study was to compare performance of logistic regression (LR) with machine learning (ML) for clinical prediction modeling in the literature. STUDY DESIGN AND SETTING: We conducted a Medline literature search (1/2016 to 8/2017) and extracted comparisons between LR and ML models for binary outcomes. RESULTS: We included 71 of 927 studies. The median sample size was 1,250 (range 72-3,994,872), with 19 predictors considered (range 5-563) and eight events per predictor (range 0.3-6,697). The most common ML methods were classification trees, random forests, artificial neural networks, and support vector machines. In 48 (68%) studies, we observed potential bias in the validation procedures. Sixty-four (90%) studies used the area under the receiver operating characteristic curve (AUC) to assess discrimination. Calibration was not addressed in 56 (79%) studies. We identified 282 comparisons between an LR and ML model (AUC range, 0.52-0.99). For 145 comparisons at low risk of bias, the difference in logit(AUC) between LR and ML was 0.00 (95% confidence interval, -0.18 to 0.18). For 137 comparisons at high risk of bias, logit(AUC) was 0.34 (0.20-0.47) higher for ML. CONCLUSION: We found no evidence of superior performance of ML over LR. Improvements in methodology and reporting are needed for studies that compare modeling algorithms.",2019,10.1016/j.jclinepi.2019.02.004,110,NA,12-22,eng,1878-5921 0895-4356,"Machine learning and Humans and Algorithms and Sensitivity and Specificity and Calibration and Predictive Value of Tests and Area Under Curve and Outcome Assessment, Health Care and AUC and Logistic regression and *Models, Theoretical and *Supervised Machine Learning and *Logistic Models and Clinical prediction models and Reporting",NA,NA,2019/06//undefined,J Clin Epidemiol,NA,NA,NA,NA
Hoffman_2016_Joofclep,JOUR,Automatically quantifying the scientific quality and sensationalism of news records mentioning pandemics: validating a maximum entropy machine-learning model,"Hoffman, Steven J. and Justicz, Victoria",Journal of clinical epidemiology,"OBJECTIVE: To develop and validate a method for automatically quantifying the scientific quality and sensationalism of individual news records. STUDY DESIGN: After retrieving 163,433 news records mentioning the Severe Acute Respiratory Syndrome (SARS) and H1N1 pandemics, a maximum entropy model for inductive machine learning was used to identify relationships among 500 randomly sampled news records that correlated with systematic human assessments of their scientific quality and sensationalism. These relationships were then computationally applied to automatically classify 10,000 additional randomly sampled news records. The model was validated by randomly sampling 200 records and comparing human assessments of them to the computer assessments. RESULTS: The computer model correctly assessed the relevance of 86% of news records, the quality of 65% of records, and the sensationalism of 73% of records, as compared to human assessments. Overall, the scientific quality of SARS and H1N1 news media coverage had potentially important shortcomings, but coverage was not too sensationalizing. Coverage slightly improved between the two pandemics. CONCLUSION: Automated methods can evaluate news records faster, cheaper, and possibly better than humans. The specific procedure implemented in this study can at the very least identify subsets of news records that are far more likely to have particular scientific and discursive qualities.",2016,10.1016/j.jclinepi.2015.12.010,75,NA,47-55,eng,1878-5921 0895-4356,"Machine learning and Humans and Databases, Factual and Mass media and Sensitivity and Specificity and Reproducibility of Results and Pandemics and Validation studies and Information Dissemination/*methods and *Pandemics and Influenza, Human/*epidemiology and Machine Learning/*standards and Influenza A Virus, H1N1 Subtype and Health communication and Mass Media/*standards and News and Severe Acute Respiratory Syndrome/*epidemiology",NA,NA,2016/07//undefined,J Clin Epidemiol,NA,NA,NA,NA
Noonan_2017_Joofclep,JOUR,Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 3: patient-reported outcomes can facilitate shared decision-making and guide self-management,"Noonan, Vanessa K. and Lyddiatt, Anne and Ware, Patrick and Jaglal, Susan B. and Riopelle, Richard J. and Bingham, Clifton O. 3rd and Figueiredo, Sabrina and Sawatzky, Richard and Santana, Maria and Bartlett, Susan J. and Ahmed, Sara",Journal of clinical epidemiology,"BACKGROUND: There is a shift toward making health care patient centered, whereby patients are part of medical decision-making and take responsibility for managing their health. Patient-reported outcomes (PROs) capture the patient voice and can be used to engage patients in medical decision-making. OBJECTIVE: The objective of this paper is to present important factors from patients', clinicians', researchers', and decision-makers' perspectives that influence successful adoption of PROs in clinical practice. Factors recommended in this paper were informed by a patient partner. DISCUSSION: Based on themes arising from the Montreal Accord proceedings, we describe factors that influence the adoption of PROs and how PROs can have a positive effect by enhancing communication and providing opportunities to engage patients, carers, and clinicians in care. Consideration of patient factors (e.g., health literacy), family support and networks (e.g., peer-support networks), technology (e.g., e-health), and health care system factors (e.g., resources to implement PROs) is necessary to ensure PROs are successfully adopted. PRO evaluation plans most likely to succeed over the long term are those incorporating PROs identified by patients as necessary for self-management and that coincide with providers' needs for collaboratively developing treatment plans with patients and families.",2017,10.1016/j.jclinepi.2017.04.017,89,NA,125-135,eng,1878-5921 0895-4356,Humans and Delivery of Health Care and Forecasting and Self-management and Canada and Evaluation and Congresses as Topic and Self-report and *Decision Making and *Self Care and *Patient Reported Outcome Measures and Patient-centered care and Shared decision-making and Patient-reported outcome measures,NA,NA,2017/09//undefined,J Clin Epidemiol,NA,NA,NA,NA
Li_2014_MMWMorandmorweerep,JOUR,"Diabetes self-management education and training among privately insured persons with newly diagnosed diabetes--United States, 2011-2012","Li, Rui and Shrestha, Sundar S. and Lipman, Ruth and Burrows, Nilka R. and Kolb, Leslie E. and Rutledge, Stephanie",MMWR. Morbidity and mortality weekly report,"Diabetes is a complex chronic disease that requires active involvement of patients in its management. Diabetes self-management education and training (DSMT), ""the ongoing process of facilitating the knowledge, skill, and ability necessary for prediabetes and diabetes self-care,"" is an important component of integrated diabetes care. It is an intervention in which patients learn about diabetes and how to implement the self-management that is imperative to control the disease. The curriculum of DSMT often includes the diabetes disease process and treatment options; healthy lifestyle; blood glucose monitoring; preventing, detecting and treating diabetes complications; and developing personalized strategies for decision making. The American Diabetes Association recommends providing DSMT to those with newly diagnosed diabetes, because data suggest that when diabetes is first diagnosed is the time when patients are most receptive to such engagement. However, little is known about the proportion of persons with newly diagnosed diabetes participating in DSMT. CDC analyzed data from the Marketscan Commercial Claims and Encounters database (Truven Health Analytics) for the period 2009-2012 to estimate the claim-based proportion of privately insured adults (aged 18-64 years) with newly diagnosed diabetes who participated in DSMT during the first year after diagnosis. During 2011-2012, an estimated 6.8% of privately insured, newly diagnosed adults participated in DSMT during the first year after diagnosis of diabetes. These data suggest that there is a large gap between the recommended guideline and current practice, and that there is both an opportunity and a need to enhance rates of DSMT participation among persons newly diagnosed with diabetes.",2014,NA,63,46,1045-1049,eng,1545-861X 0149-2195,"United States and Humans and Female and Male and Adolescent and Adult and Middle Aged and Young Adult and *Self Care and Diabetes Mellitus/*therapy and *Patient Education as Topic and Insurance, Health/*statistics & numerical data and *Private Sector",NA,NA,2014/11/21/,MMWR Morb Mortal Wkly Rep,NA,NA,NA,NA
Martin_2020_Joofclep,JOUR,"Toward a framework for the design, implementation, and reporting of methodology scoping reviews","Martin, Glen P. and Jenkins, David A. and Bull, Lucy and Sisk, Rose and Lin, Lijing and Hulme, William and Wilson, Anthony and Wang, Wenjuan and Barrowman, Michael and Sammut-Powell, Camilla and Pate, Alexander and Sperrin, Matthew and Peek, Niels",Journal of clinical epidemiology,"BACKGROUND AND OBJECTIVE: In view of the growth of published articles, there is an increasing need for studies that summarize scientific research. An increasingly common review is a ""methodology scoping review,"" which provides a summary of existing analytical methods, techniques and software that have been proposed or applied in research articles to address an analytical problem or further an analytical approach. However, guidelines for their design, implementation, and reporting are limited. METHODS: Drawing on the experiences of the authors, which were consolidated through a series of face-to-face workshops, we summarize the challenges inherent in conducting a methodology scoping review and offer suggestions of best practice to promote future guideline development. RESULTS: We identified three challenges of conducting a methodology scoping review. First, identification of search terms; one cannot usually define the search terms a priori, and the language used for a particular method can vary across the literature. Second, the scope of the review requires careful consideration because new methodology is often not described (in full) within abstracts. Third, many new methods are motivated by a specific clinical question, where the methodology may only be documented in supplementary materials. We formulated several recommendations that build upon existing review guidelines. These recommendations ranged from an iterative approach to defining search terms through to screening and data extraction processes. CONCLUSION: Although methodology scoping reviews are an important aspect of research, there is currently a lack of guidelines to standardize their design, implementation, and reporting. We recommend a wider discussion on this topic.",2020,10.1016/j.jclinepi.2020.07.014,127,NA,191-197,eng,1878-5921 0895-4356,Humans and Systematic reviews and *Review Literature as Topic and Research Design/*standards and Reporting and Methodology scoping reviews and Scoping reviews and Study design and Systematic Reviews as Topic/*methods,NA,NA,2020/11//undefined,J Clin Epidemiol,NA,NA,NA,NA
van.der.Weijden_2012_Joofclep,JOUR,Clinical practice guidelines and patient decision aids. An inevitable relationship,"van der Weijden, Trudy and Boivin, Antoine and Burgers, Jako and Schunemann, Holger J. and Elwyn, Glyn",Journal of clinical epidemiology,"As health professionals and patients are moving toward shared models of decision making, there is a growing need for integrated decision support tools that facilitate uptake of best evidence in routine clinical practice in a patient-centered manner. This article charts the landscape of clinical practice guidelines (CPGs) and patient decision aids. Decision support tools for medical practice can be mapped on two dimensions. (1) The target user and his or her level of decision making; either for groups of patients or for an individual patient and (2) the level of uncertainty: either supporting more directive decision making (behavior support) in the case of strong recommendations with a single best option or supporting dialog (deliberation support) on the pros and cons of different options in the case of conditional (or weak) recommendations. We conclude that it is important to establish closer links between CPGs and patient decision aids, through collaborative development of both. Such collaboration will encourage the design of decision support tools for professionals and patients who share the same evidence and the aim to increase the quality of decision making between doctor and patient. This could facilitate the implementation of CPGs and shared decision making in clinical practice.",2012,10.1016/j.jclinepi.2011.10.007,65,6,584-589,eng,1878-5921 0895-4356,Humans and Physician-Patient Relations and Patient Education as Topic and Health Services Needs and Demand and *Decision Making and *Practice Guidelines as Topic and *Decision Support Techniques and *Patient Participation and *Physician's Role,NA,NA,2012/06//undefined,J Clin Epidemiol,NA,NA,NA,NA
Forrest_2021_Joofclep,JOUR,"PCORnet(R) 2020: current state, accomplishments, and future directions","Forrest, Christopher B. and McTigue, Kathleen M. and Hernandez, Adrian F. and Cohen, Lauren W. and Cruz, Henry and Haynes, Kevin and Kaushal, Rainu and Kho, Abel N. and Marsolo, Keith A. and Nair, Vinit P. and Platt, Richard and Puro, Jon E. and Rothman, Russell L. and Shenkman, Elizabeth A. and Waitman, Lemuel Russell and Williams, Neely A. and Carton, Thomas W.",Journal of clinical epidemiology,"OBJECTIVE: To describe PCORnet, a clinical research network developed for patient-centered outcomes research on a national scale. STUDY DESIGN AND SETTING: Descriptive study of the current state and future directions for PCORnet. We conducted cross-sectional analyses of the health systems and patient populations of the 9 Clinical Research Networks and 2 Health Plan Research Networks that are part of PCORnet. RESULTS: Within the Clinical Research Networks, electronic health data are currently collected from 337 hospitals, 169,695 physicians, 3,564 primary care practices, 338 emergency departments, and 1,024 community clinics. Patients can be recruited for prospective studies from any of these clinical sites. The Clinical Research Networks have accumulated data from 80 million patients with at least one visit from 2009 to 2018. The PCORnet Health Plan Research Network population of individuals with a valid enrollment segment from 2009 to 2019 exceeds 60 million individuals, who on average have 2.63 years of follow-up. CONCLUSION: PCORnet's infrastructure comprises clinical data from a diverse cohort of patients and has the capacity to rapidly access these patient populations for pragmatic clinical trials, epidemiological research, and patient-centered research on rare diseases.",2021,10.1016/j.jclinepi.2020.09.036,129,NA,60-67,eng,1878-5921 0895-4356,Electronic health records and Humans and Big data and Prospective Studies and Learning health system and *Patient Selection and *Treatment Outcome and Electronic Health Records/statistics & numerical data and Information Dissemination/methods and *Biomedical Research/methods/organization & administration and Clinical research network and Distributed data network and Health plan research network and Information Services/*organization & administration and PCORnet and Pragmatic clinical trials and Pragmatic Clinical Trials as Topic/methods,NA,NA,2021/01//undefined,J Clin Epidemiol,NA,NA,NA,NA
Bentley_2018_Injoofep,JOUR,The impact of social housing on mental health: longitudinal analyses using marginal structural models and machine learning-generated weights,"Bentley, Rebecca and Baker, Emma and Simons, Koen and Simpson, Julie A. and Blakely, Tony",International journal of epidemiology,"BACKGROUND: Social housing may provide an affordable and secure residential environment, but has also been associated with stigma, poor housing conditions and locational disadvantage. We examined the cumulative effect of additional years, and tenure security (number of transitions in/out), of social housing on mental health in a large cohort of lower-income Australians. METHODS: We analysed a longitudinal panel survey that annually collected information on tenure and health from 2001 to 2013. To address the time-varying effect of previous health on social housing occupancy, we used marginal structural models. Stabilized inverse probabilities of treatment weights were generated using ensemble learning to improve prediction. To address remaining residual imbalance across covariates, double adjustment was made by additionally including baseline covariates in models. Mental health was measured using the Mental Health Short-Form summary measure of the SF-36 (MH), and psychological distress was measured using the Kessler Psychological Distress Scale (K10). RESULTS: People who had continuous exposure to social housing had worse mental health on average than people continuously occupying other tenures. The worst mental health outcomes, however, were observed for people who made multiple transitions. Mental health deteriorated and psychological distress increased with number of transitions: MH -1.04 [95% confidence interval (CI) -2.16; 0.09) and K10 0.56 (95% CI 0.12; 1.00). Estimates are in the order of 6% (MH) and 9% (K10) of one standard deviation for each measure. CONCLUSIONS: The more transitions people made in/out of social housing, the greater the impact on mental health and psychological distress, supporting the case for provision of more stable forms of social housing.",2018,10.1093/ije/dyy116,47,5,1414-1422,eng,1464-3685 0300-5771,"Poverty and Humans and Female and Male and Adult and Middle Aged and Aged and Longitudinal Studies and *Mental Health and *Social Stigma and Australia/epidemiology and *Models, Statistical and *Machine Learning and Stress, Psychological/*epidemiology and Public Housing/*statistics & numerical data",NA,NA,2018/10/01/,Int J Epidemiol,NA,NA,NA,NA
Bolt_2014_Joofclep,JOUR,Reducing questionnaire length did not improve physician response rate: a randomized trial,"Bolt, Eva E. and van der Heide, Agnes and Onwuteaka-Philipsen, Bregje D.",Journal of clinical epidemiology,"OBJECTIVES: To examine the effect of reducing questionnaire length on the response rate in a physician survey. STUDY DESIGN AND SETTING: A postal four double-page questionnaire on end-of-life decision making was sent to a random sample of 1,100 general practitioners, 400 elderly care physicians, and 500 medical specialists. Another random sample of 500 medical specialists received a shorter questionnaire of two double pages. After 3 months and one reminder, all nonresponding physicians received an even shorter questionnaire of one double page. RESULTS: Total response was 64% (1,456 of 2,269 eligible respondents). Response rate of medical specialists for the four double-page questionnaire was equal to that of the two double-page questionnaire (190 and 191 questionnaires were returned, respectively). The total response rate increased from 53% to 64% after sending a short one double-page questionnaire (1,203-1,456 respondents). CONCLUSION: The results of our study suggest that reducing the length of a long questionnaire in a physician survey does not necessarily improve response rate. To improve response rate and gather more information, researchers could decide to send a drastically shortened version of the questionnaire to nonresponders.",2014,10.1016/j.jclinepi.2013.09.012,67,4,477-481,eng,1878-5921 0895-4356,Data collection and Humans and Questionnaire design and *Decision Making and *Surveys and Questionnaires and Physicians/*psychology and Terminal Care/*methods/*psychology and Health Care Surveys/*methods and Health-care surveys and Physician surveys and Questionnaire length and Response rate,NA,NA,2014/04//undefined,J Clin Epidemiol,NA,NA,NA,NA
Bingham_2017_Joofclep,JOUR,Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 4: patient-reported outcomes can inform clinical decision making in chronic care,"Bingham, Clifton O. 3rd and Noonan, Vanessa K. and Auger, Claudine and Feldman, Debbie E. and Ahmed, Sara and Bartlett, Susan J.",Journal of clinical epidemiology,"BACKGROUND: Providing patient-centered health care requires that patient needs, preferences, and valued outcomes are more fully integrated into all decisions. Patient-reported outcome (PRO) measures provide unique information from the patient perspective on overall health, symptoms, burden, and treatment response. OBJECTIVE: We sought to describe applications of PROs in clinical settings and considerations for implementation from the perspectives of PRO researchers, clinicians, administrators, policy makers, and patients attending a multidisciplinary meeting. DISCUSSION: Clinical applications of PROs include individual level use for medical decision making and aggregate use for comparative effectiveness research, program evaluation, quality improvement, and performance assessments. Considerations of feasibility on workflow impact and patient burden, display of results, and administration frequency are important. PROs with strong psychometric properties, actionable thresholds, and interpretable results should be selected. We provide current exemplars of PRO use in various clinical applications, initial lessons learned, and highlight conceptual, logistical, and consequential considerations of PRO data collection. A research agenda is proposed to address critical knowledge gaps. In conclusion, PROs can be used in clinical settings to support patient-centered care. This requires an assessment of feasibility in the intended setting of use, measurement considerations, and process measures to optimize integration and use.",2017,10.1016/j.jclinepi.2017.04.014,89,NA,136-141,eng,1878-5921 0895-4356,Humans and Canada and Patient care and Congresses as Topic and *Patient Reported Outcome Measures and Clinical Decision-Making/*methods and *Long-Term Care and Clinical practice and Patient-reported outcomes and Patient-centered outcomes,NA,NA,2017/09//undefined,J Clin Epidemiol,NA,NA,NA,NA
Schunemann_2016_Joofclep,JOUR,GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health,"Schunemann, Holger J. and Mustafa, Reem and Brozek, Jan and Santesso, Nancy and Alonso-Coello, Pablo and Guyatt, Gordon and Scholten, Rob and Langendam, Miranda and Leeflang, Mariska M. and Akl, Elie A. and Singh, Jasvinder A. and Meerpohl, Joerg and Hultcrantz, Monica and Bossuyt, Patrick and Oxman, Andrew D.",Journal of clinical epidemiology,"OBJECTIVES: To describe the grading of recommendations assessment, development and evaluation (GRADE) interactive evidence to decision (EtD) frameworks for tests and test strategies for clinical, public health, or coverage decisions. STUDY DESIGN AND SETTING: As part of the GRADE Working Group's DECIDE project, we conducted workshops, user testing with systematic review authors, guideline developers and other decision makers, and piloted versions of the EtD framework. RESULTS: EtD frameworks for tests share the structure, explicitness, and transparency of other EtD frameworks. They require specifying the purpose of the test, linked or related management, and the key outcomes of concern for different test results and subsequent management. The EtD criteria address test accuracy and assessments of the certainty of the additional evidence necessary for decision making. When there is no direct evidence of test effects on patient-important outcomes, formal or informal modeling is needed to estimate effects. We describe the EtD criteria based on examples developed with GRADEpro (www.gradepro.org), GRADE's software that also allows development and dissemination of interactive summary of findings tables. CONCLUSION: EtD frameworks for developing recommendations and making decisions about tests lay out the sequential steps in reviewing and assessing the different types of evidence that need to be linked.",2016,10.1016/j.jclinepi.2016.01.032,76,NA,89-98,eng,1878-5921 0895-4356,"Decision-making and Humans and Guidelines and Educational Measurement/*standards and GRADE and Clinical Competence/*standards and *Guidelines as Topic and Recommendations and Evidence-Based Medicine/*standards and Public Health/*education and Education, Medical/*standards and GRADEpro and Summary of findings and Tests",NA,NA,2016/08//undefined,J Clin Epidemiol,NA,NA,NA,NA
Clare_2019_Injoofep,JOUR,Causal models adjusting for time-varying confounding-a systematic review of the literature,"Clare, Philip J. and Dobbins, Timothy A. and Mattick, Richard P.",International journal of epidemiology,"BACKGROUND: Obtaining unbiased causal estimates from longitudinal observational data can be difficult due to exposure-affected time-varying confounding. The past decade has seen considerable development in methods for analysing such complex longitudinal data. However, the extent to which those methods have been implemented is unclear. This study describes and characterizes the state of the field in methods adjusting for exposure-affected time-varying confounding, and examines their use in the literature. METHODS: We systematically reviewed the literature from 2000 to 2016 for studies adjusting for time-dependent confounding, including use of specific methods like inverse probability of treatment weighting (IPTW). Articles were coded based on the methods used and, for applied articles, the topic areas covered. RESULTS: We screened 4239 abstracts, and subsequently reviewed 1100 articles, leaving 542 relevant articles in the analyses. The number of published articles increased from two in 2000, to 112 in 2016. This increase was primarily in applied articles using IPTW, which increased from one study in 2000, to 90 in 2016. Of the 432 studies with applications to observed data, 60.9% were on at least one of: HIV (30.6%), cardiopulmonary health (13.2%), kidney disease (11.8%) or mental health (10.0%). CONCLUSIONS: There has been marked growth in reports addressing exposure-affected time-varying confounding. This was driven by work in a small number of topic areas, with other areas showing relatively little uptake. In addition, despite developments in more advanced methods such doubly robust techniques and estimation via machine learning, implementation has been largely concentrated on the simpler, yet potentially less robust, IPTW.",2019,10.1093/ije/dyy218,48,1,254-265,eng,1464-3685 0300-5771,"Humans and Health Status and Probability and Bias and Mental Health and Computer Simulation and Causal inference and *Models, Statistical and *Machine Learning and *Data Interpretation, Statistical and *Causality and *Confounding Factors, Epidemiologic and G-computation and g-estimation and marginal structural models and structural nested models targeted maximum likelihood estimation and time-varying confounding",NA,NA,2019/02/01/,Int J Epidemiol,NA,NA,NA,NA
Lijmer_2009_Joofclep,JOUR,Various randomized designs can be used to evaluate medical tests,"Lijmer, Jeroen G. and Bossuyt, Patrick M. M.",Journal of clinical epidemiology,"OBJECTIVE: To explore designs for evaluating the prognostic and predictive value of medical tests and their effect on patient outcome. STUDY DESIGN: Theoretical analysis with examples from the medical literature. RESULTS: For evaluating the prognostic value of a test, one can include the test at baseline in prognostic studies. To evaluate the value of test in predicting treatment outcome, the test results can be used as baseline information in randomized controlled trials of treatment. To compare the prognostic or predictive value of two or more tests, the test result combinations can be used as baseline information. To evaluate the effect on patient outcome, randomized controlled trials of test strategies are an option. Randomization can apply to all tested or be restricted to specific subgroups, such as those with discordant test results, to increase the efficiency of trials. CONCLUSION: The prognostic and predictive value of medical tests can and should be evaluated, to demonstrate the test's ability to guide clinical decision making and to improve patient outcome. Various randomized designs can be used to evaluate the effects on testing on patient outcome.",2009,10.1016/j.jclinepi.2008.06.017,62,4,364-373,eng,1878-5921 0895-4356,Prognosis and Predictive Value of Tests and Research Design and Randomized Controlled Trials as Topic/*methods and Diagnostic Techniques and Procedures/*standards,NA,NA,2009/04//undefined,J Clin Epidemiol,NA,NA,NA,NA
Barker_2021_Joofclep,JOUR,Guidelines rarely used GRADE and applied methods inconsistently: A methodological study of Australian guidelines,"Barker, Timothy Hugh and Dias, Mafalda and Stern, Cindy and Porritt, Kylie and Wiechula, Rick and Aromataris, Edoardo and Brennan, Sue and Schunemann, Holger J. and Munn, Zachary",Journal of clinical epidemiology,"OBJECTIVES: The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach is accepted methodology to assess the certainty of the evidence included in systematic reviews and clinical practice guidelines. The GRADE approach is endorsed globally, in Australia, the National Health and Medical Research Council advocated for the use of the GRADE approach in 2011. The purpose of this methodological review was to assess how GRADE has been adopted for Australian practice guidelines. STUDY DESIGN AND SETTING: This methodological review searched of the National Health and Medical Research Council Clinical Practice Guidelines Portal from 2011 to 2018, in an effort to retrieve all practice guidelines available via this medium. RESULTS: 240 guidelines were retrieved authored by 51 different organizations. 15 guidelines followed GRADE methodology. Application of GRADE methods varied between guidelines, some misreported and altered aspects of the GRADE process. Guidelines that closely adhered to the guidance from the GRADE Working Group scored higher in domain 3 (rigor of development) of the Appraisal of Guidelines for Research and Evaluation II tool, indicating a positive linear relationship between GRADE adherence and rigor of development scores. CONCLUSION: The results of our project suggest that the use of GRADE in Australian guidelines is increasing, however, strategies to increase uptake and reporting within the guideline community need to be explored.",2021,10.1016/j.jclinepi.2020.10.017,130,NA,125-134,eng,1878-5921 0895-4356,"Software and Humans and Guidelines and Australia and GRADE and Delivery of Health Care/*standards and *Decision Making, Computer-Assisted and Clinical and Practice Guidelines as Topic/*standards and NHMRC and Systematic Reviews as Topic/*standards",NA,NA,2021/02//undefined,J Clin Epidemiol,NA,NA,NA,NA
Schunemann_2020_Joofclep,JOUR,"Using GRADE in situations of emergencies and urgencies: certainty in evidence and recommendations matters during the COVID-19 pandemic, now more than ever and no matter what","Schunemann, Holger J. and Santesso, Nancy and Vist, Gunn E. and Cuello, Carlos and Lotfi, Tamara and Flottorp, Signe and Davoli, Marina and Mustafa, Reem and Meerpohl, Joerg J. and Alonso-Coello, Pablo and Akl, Elie A.",Journal of clinical epidemiology,"OBJECTIVES: The public, policy makers, and science communities are subject to many false, uninformed, overly optimistic, premature, or simply ridiculous health claims. The coronavirus disease 2019 (COVID-19) pandemic and its context is a paramount example for such claims. In this article, we describe why expressing the certainty in evidence to support a decision is critical and why the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach matters now, perhaps more than ever and no matter what the specific topic is in relation to COVID-19. We finally also offer suggestions for how it can be used appropriately to support decision-making at global, national, and local level when emergency, urgent or rapid responses are needed. STUDY DESIGN AND SETTING: This is an invited commentary to address the objectives above building on examples from the recent COVID-19 pandemic. This includes an iterative discussion of examples and development of guidance. RESULTS: The GRADE approach is a transparent and structured method for assessing the certainty of evidence and when developing recommendations that requires little additional time. We describe why emergency, urgent, or rapid responses do not justify omitting this critical assessment of the evidence. In situations of emergencies and urgencies, such as the COVID-19 pandemic, GRADE can similarly be used to express and convey certainty in intervention effects, test accuracy, risk and prognostic factors, consequences of public health measures, and qualitative bodies of evidence. CONCLUSIONS: Assessing and communicating the certainty of evidence during the COVID-19 pandemic is critical. Those offering evidence synthesis or making recommendations should use transparent ratings of the body of evidence supporting a claim regardless of time that is available or needed to provide this response.",2020,10.1016/j.jclinepi.2020.05.030,127,NA,202-207,eng,1878-5921 0895-4356,"COVID-19 and Humans and Guidelines and Decision Support Techniques and Pandemics and Emergencies and Systematic reviews and GRADE and *Decision Making and *Pandemics and Emergency Medical Services/*organization & administration and Recommendations and *Coronavirus Infections and *Pneumonia, Viral",NA,NA,2020/11//undefined,J Clin Epidemiol,NA,NA,NA,NA
Puljak_2020_Joofclep,JOUR,Data extraction methods: an analysis of internal reporting discrepancies in single manuscripts and practical advice,"Puljak, Livia and Riva, Nicoletta and Parmelli, Elena and Gonzalez-Lorenzo, Marien and Moja, Lorenzo and Pieper, Dawid",Journal of clinical epidemiology,"BACKGROUND: Data extraction from reports about experimental or observational studies is a crucial methodological step informing evidence syntheses, such as systematic reviews (SRs) and overviews of SRs. Reporting discrepancies were defined as pairs of statements that could not both be true. Authors of SRs and overviews of SRs can encounter reporting discrepancies among multiple sources when extracting data-a manuscript and a conference abstract, and a manuscript and a clinical trial registry. However, these discrepancies can also be found within a single manuscript published in a scientific journal. OBJECTIVES: Hereby, we describe examples of internal reporting discrepancies that can be found in a single source, with the aim of raising awareness among authors of SRs and overviews of SRs about such potential methodological issues. CONCLUSIONS: Authors of SRs and overviews of SRs should check whether the same information is reported in multiple places within a study and compare that information. Independent data extraction by two reviewers increases the chance of finding discrepancies, if they exist. We provide advice on how to deal with different types of discordances and how to report such discordances when conducting SRs and overviews of SRs.",2020,10.1016/j.jclinepi.2019.09.003,117,NA,158-164,eng,1878-5921 0895-4356,"Humans and Evidence-Based Medicine and Decision Making and Data and Errors and Data extraction and Systematic reviews and *Data Analysis and Systematic Reviews as Topic and Research Design/*standards and Reporting and Discrepancies and Manuscripts, Medical as Topic",NA,NA,2020/01//undefined,J Clin Epidemiol,NA,NA,NA,NA
Chatelan_2019_Injoofep,JOUR,Precision nutrition: hype or hope for public health interventions to reduce obesity?,"Chatelan, Angeline and Bochud, Murielle and Frohlich, Katherine L.",International journal of epidemiology,"High-income countries are experiencing an obesity epidemic that follows a socioeconomic gradient, affecting groups of lower socioeconomic status disproportionately. Recent clinical findings have suggested new perspectives for the prevention and treatment of obesity, using personalized dietary approaches. Precision nutrition (PN), also called personalized nutrition, has been developed to deliver more preventive and practical dietary advice than 'one-size-fits-all' guidelines. With interventions becoming increasingly plausible at a large scale thanks to artificial intelligence and smartphone applications, some have begun to view PN as a novel way to deliver the right dietary intervention to the right population. We argue that large-scale PN, if taken alone, might be of limited interest from a public health perspective. Building on Geoffrey Rose's theory regarding the differences in individual and population causes of disease, we show that large-scale PN can only address some individual causes of obesity (causes of cases). This individual-centred approach is likely to have a small impact on the distribution of obesity at a population level because it ignores the population causes of obesity (causes of incidence). The latter are embedded in the populations' social, cultural, economic and political contexts that make environments obesogenic. Additionally, the most socially privileged groups in the population are the most likely to respond to large-scale PN interventions. This could have the undesirable effect of widening social inequalities in obesity. We caution public health actors that interventions based only on large-scale PN are unlikely, despite current expectations, to improve dietary intake or reduce obesity at a population level.",2019,10.1093/ije/dyy274,48,2,332-342,eng,1464-3685 0300-5771,Humans and Socioeconomic Factors and obesity and Health Promotion/*methods and *Precision Medicine and *Diet and *Public Health Practice and Precision nutrition and Obesity/*prevention & control and personalized nutrition and obesogenic environments and population interventions and social inequalities in health,NA,NA,2019/04/01/,Int J Epidemiol,NA,NA,NA,NA
Boutron_2020_Joofclep,JOUR,Future of evidence ecosystem series: 1. Introduction Evidence synthesis ecosystem needs dramatic change,"Boutron, Isabelle and Crequit, Perrine and Williams, Hywel and Meerpohl, Joerg and Craig, Jonathan C. and Ravaud, Philippe",Journal of clinical epidemiology,"OBJECTIVES: This article presents why the planning, conduct, and reporting of systematic reviews and meta-analyses of therapeutic interventions are suboptimal. STUDY DESIGN AND SETTING: We present an overview of the limitations of the current system of evidence synthesis for therapeutic interventions. RESULTS: Systematic reviews and meta-analyses are a cornerstone of health care decisions. However, despite the increasing a number of published systematic reviews of therapeutic interventions, the current evidence synthesis ecosystem is not properly addressing stakeholders' needs. The current production process leads to a series of disparate systematic reviews because of erratic and inefficient planning with a process that is not always comprehensive and is prone to bias. Evidence synthesis depends on the quality of primary research, so primary research that is not available is biased or selectively reported raises important concerns. Moreover, the lack of interactions between the community of primary research producers and systematic reviewers impedes the optimal use of data. The context has considerably evolved, with ongoing research innovations, a new medical approach with the end of the one-size-fits-all approach, more available data, and new patient expectations. All these changes must be introduced into the future evidence ecosystem. CONCLUSION: Dramatic changes are needed to enable this future ecosystem to become user driven and user oriented and more useful for decision-making.",2020,10.1016/j.jclinepi.2020.01.024,123,NA,135-142,eng,1878-5921 0895-4356,Decision-making and Humans and Meta-analysis and Bias and Methods and Systematic review and *Meta-Analysis as Topic and Research Design/*standards and Systematic Reviews as Topic/*standards and Data Management/*methods/*standards and Evidence synthesis ecosystem and Waste in research,NA,NA,2020/07//undefined,J Clin Epidemiol,NA,NA,NA,NA
Clarke_2016_Joofclep,JOUR,A randomized trial of fellowships for early career researchers finds a high reliability in funding decisions,"Clarke, Philip and Herbert, Danielle and Graves, Nick and Barnett, Adrian G.",Journal of clinical epidemiology,"OBJECTIVES: Funding for early career researchers in Australia's largest medical research funding scheme is determined by a competitive peer-review process using a panel of four reviewers. The purpose of this experiment was to appraise the reliability of funding by duplicating applications that were considered by separate grant review panels. STUDY DESIGN AND METHODS: Sixty duplicate applications were considered by two independent grant review panels that were awarding funding for Australia's National Health and Medical Research Council. Panel members were blinded to which applications were included in the experiment and to whether it was the original or duplicate application. Scores were compared across panels using Bland-Altman plots to determine measures of agreement, including whether agreement would have impacted on actual funding. RESULTS: Twenty-three percent of the applicants were funded by both panels and 60 percent were not funded by both, giving an overall agreement of 83 percent [95% confidence interval (CI): 73%, 92%]. The chance-adjusted agreement was 0.75 (95% CI: 0.58, 0.92). CONCLUSION: There was a comparatively high level of agreement when compared with other types of funding schemes. Further experimental research could be used to determine if this higher agreement is due to nature of the application, the composition of the assessment panel, or the characteristics of the applicants.",2016,10.1016/j.jclinepi.2015.04.010,69,NA,147-151,eng,1878-5921 0895-4356,Research and Decision Making and Single-Blind Method and Australia and Funding and Peer review and Reproducibility of Results and Reliability and Fellowship and Research/*economics and *Fellowships and Scholarships and Career,NA,NA,2016/01//undefined,J Clin Epidemiol,NA,NA,NA,NA
Baduashvili_2020_Joofclep,JOUR,How to understand and teach P values: a diagnostic test framework,"Baduashvili, Amiran and Evans, Arthur T. and Cutler, Todd",Journal of clinical epidemiology,OBJECTIVES: The aim of the tutorial is to help educators address misconceptions about P values and provide a tool that can be used to teach a more contemporary interpretation. STUDY DESIGN AND SETTING: A scripted tutorial using problem-based learning and a diagnostic test analogy to deconstruct the misunderstandings about P values and develop a more Bayesian approach to study interpretation. RESULTS: A diagnostic test analogy is an effective teaching tool. Learners' understanding of Bayes' theorem in diagnostic testing can be used as a bridge to the realization that the prestudy probability of a true difference is crucial for study interpretation. The analogy has several caveats and shortcomings. The limitations of this analogy and the conceptual difficulties with the Bayesian study analyses are addressed. CONCLUSION: P values do not provide the information many assume they do-they are not equivalent to a probability of a chance finding. This tutorial helps move learners from these incorrect notions to new insights.,2020,10.1016/j.jclinepi.2020.03.003,122,NA,49-55,eng,1878-5921 0895-4356,"Evidence-based medicine and Humans and Female and Male and Adult and Middle Aged and Bayes Theorem and *Data Interpretation, Statistical and *Clinical Decision-Making and *Guidelines as Topic and Medical education and Biomedical Research/*standards and Diagnostic Tests, Routine/*standards and *Probability and Research Personnel/*education and Problem-based learning and Bayes' theorem and Hypothesis testing and P-values",NA,NA,2020/06//undefined,J Clin Epidemiol,NA,NA,NA,NA
Bossuyt_2020_Joofclep,JOUR,An analysis reveals differences between pragmatic and explanatory diagnostic accuracy studies,"Bossuyt, Patrick M. and Olsen, Maria and Hyde, Chris and Cohen, Jeremie F.",Journal of clinical epidemiology,"OBJECTIVES: The objective of this study was to clarify a difference between two approaches while evaluating the diagnostic accuracy of medical tests, labeled here as ""pragmatic"" vs. ""explanatory"" studies. METHODS: Using the definitions and characteristics described by Schwartz and Lellouch for randomized trials of interventions, and Schwartz' more general distinction between a pragmatic and an explanatory approach in medical research, we define a similar continuum for diagnostic accuracy studies. Explanatory studies aim to better understand the behavior of a test; pragmatic ones are done to support recommendations or decisions about using the test in clinical practice. RESULTS: Pragmatic test accuracy studies differ from explanatory test accuracy studies in several ways. The difference in aims has implications for key elements of study design, such as the study eligibility criteria, the recruitment of patients, the reference standard, and the choice of the statistical analysis. Explanatory accuracy studies are often designed to test a hypothesis. They are typically selective in recruitment, may include ""healthy controls,"" with a small sample size, often recruited at a single center. They ignore testing failures in the analysis and more often present their results as ROC curves. By contrast, pragmatic studies are designed to guide decision making. They ideally will recruit a single, large, and representative group of patients at multiple sites and will more often present their results as estimates of sensitivity and specificity or predictive values at a prespecified threshold. CONCLUSION: Distinguishing between a pragmatic and an explanatory approach can help in the design, analysis, and interpretation of diagnostic accuracy studies. It can clarify debates about the appropriateness of design features to the study purpose and about the validity and applicability of study findings.",2020,10.1016/j.jclinepi.2019.09.017,117,NA,29-35,eng,1878-5921 0895-4356,"Humans and Sensitivity and Specificity and Sample Size and ROC Curve and Data Accuracy and Sensitivity and Specificity and Diagnostic Tests, Routine/*standards and Research Design/*standards and Reference standard and Diagnostic accuracy and Explanatory studies and Pragmatic Clinical Trials as Topic and Pragmatic studies and Test evaluation",NA,NA,2020/01//undefined,J Clin Epidemiol,NA,NA,NA,NA
Collins_2015_Joofclep,JOUR,Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement,"Collins, Gary S. and Reitsma, Johannes B. and Altman, Douglas G. and Moons, Karel G. M.",Journal of clinical epidemiology,"Prediction models are developed to aid health care providers in estimating the probability or risk that a specific disease or condition is present (diagnostic models) or that a specific event will occur in the future (prognostic models), to inform their decision making. However, the overwhelming evidence shows that the quality of reporting of prediction model studies is poor. Only with full and clear reporting of information on all aspects of a prediction model can risk of bias and potential usefulness of prediction models be adequately assessed. The Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) Initiative developed a set of recommendations for the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes. This article describes how the TRIPOD Statement was developed. An extensive list of items based on a review of the literature was created, which was reduced after a Web-based survey and revised during a 3-day meeting in June 2011 with methodologists, health care professionals, and journal editors. The list was refined during several meetings of the steering group and in e-mail discussions with the wider group of TRIPOD contributors. The resulting TRIPOD Statement is a checklist of 22 items, deemed essential for transparent reporting of a prediction model study. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. The TRIPOD Statement is best used in conjunction with the TRIPOD explanation and elaboration document. To aid the editorial process and readers of prediction model studies, it is recommended that authors include a completed checklist in their submission (also available at www.tripod-statement.org).",2015,10.1016/j.jclinepi.2014.11.010,68,2,134-143,eng,1878-5921 0895-4356,"Humans and Multivariate Analysis and Prognosis and Decision Support Techniques and Consensus and Medical Records/*standards and *Practice Guidelines as Topic and Delivery of Health Care/*standards and *Models, Statistical and Publishing/*standards",NA,NA,2015/02//undefined,J Clin Epidemiol,NA,NA,NA,NA
Strech_2012_Joofclep,JOUR,Normative arguments and new solutions for the unbiased registration and publication of clinical trials,"Strech, Daniel",Journal of clinical epidemiology,"OBJECTIVE: To present a structured account of ethical problems and possible solutions related to selective publication and incomplete trial registration. STUDY DESIGN AND SETTING: The presentation of ethical problems and possible solutions is structured using the tools of conceptual normative analysis. RESULTS: Selective publication runs contrary to (1) principles of ethical research, such as social value and respect for participants, (2) sound medical decision making and clinical guideline development, (3) appropriate patient information, (4) public trust in clinical research, and (5) just allocation of public resources for clinical research. Reasons against the obligation of complete registration and publication of trials can be divided into (1) protection of private data and (2) commercial interests. Empirical findings indicate that selective publication and incomplete trial registration (1) are frequent, (2) extensively distort patient-relevant outcomes, and (3) affect a large number of patients. CONCLUSION: Empirical data and normative arguments outweigh their counterarguments and present a clear case in favor of an even more restrictive obligation to register trials. Institutional review boards and better-educated stakeholders might play a crucial role in facilitating unbiased registration and publication of clinical research. For evaluation purposes, the field needs better standards for study protocols.",2012,10.1016/j.jclinepi.2011.07.002,65,3,276-281,eng,1878-5921 0895-4356,"Humans and Ethics Committees, Research and *Ethics, Research and *Publication Bias and Registries/*standards and Clinical Trials as Topic/*standards and *Empirical Research and Publishing/*ethics/standards",NA,NA,2012/03//undefined,J Clin Epidemiol,NA,NA,NA,NA
Neugebauer_2013_Joofclep,JOUR,Super learning to hedge against incorrect inference from arbitrary parametric assumptions in marginal structural modeling,"Neugebauer, Romain and Fireman, Bruce and Roy, Jason A. and Raebel, Marsha A. and Nichols, Gregory A. and O'Connor, Patrick J.",Journal of clinical epidemiology,"OBJECTIVE: Clinical trials are unlikely to ever be launched for many comparative effectiveness research (CER) questions. Inferences from hypothetical randomized trials may however be emulated with marginal structural modeling (MSM) using observational data, but success in adjusting for time-dependent confounding and selection bias typically relies on parametric modeling assumptions. If these assumptions are violated, inferences from MSM may be inaccurate. In this article, we motivate the application of a data-adaptive estimation approach called super learning (SL) to avoid reliance on arbitrary parametric assumptions in CER. STUDY DESIGN AND SETTING: Using the electronic health records data from adults with new-onset type 2 diabetes, we implemented MSM with inverse probability weighting (IPW) estimation to evaluate the effect of three oral antidiabetic therapies on the worsening of glomerular filtration rate. RESULTS: Inferences from IPW estimation were noticeably sensitive to the parametric assumptions about the associations between both the exposure and censoring processes and the main suspected source of confounding, that is, time-dependent measurements of hemoglobin A1c. SL was successfully implemented to harness flexible confounding and selection bias adjustment from existing machine learning algorithms. CONCLUSION: Erroneous IPW inference about clinical effectiveness because of arbitrary and incorrect modeling decisions may be avoided with SL.",2013,10.1016/j.jclinepi.2013.01.016,66,8 Suppl,109-S99,eng,1878-5921 0895-4356,"Humans and Adult and Middle Aged and Young Adult and Aged and Time Factors and Cohort Studies and Treatment Outcome and Comparative effectiveness research and Selection bias and Confounding Factors, Epidemiologic and Disease Progression and Survival Analysis and Drug Therapy, Combination and Selection Bias and *Models, Statistical and *Data Interpretation, Statistical and Electronic Health Records/*statistics & numerical data and Randomized Controlled Trials as Topic/*statistics & numerical data and Glomerular Filtration Rate/drug effects and Comparative Effectiveness Research/statistics & numerical data and Diabetes Mellitus, Type 2/drug therapy/physiopathology and Hypoglycemic Agents/administration & dosage/therapeutic use and Inverse probability weighting and Marginal structural model and Metformin/administration & dosage/therapeutic use and Sulfonylurea Compounds/administration & dosage/therapeutic use and Super learning and Time-dependent confounding",NA,NA,2013/08//undefined,J Clin Epidemiol,NA,NA,NA,NA
Wahl_2014_Joofclep,JOUR,Standardization of depression measurement: a common metric was developed for 11 self-report depression measures,"Wahl, Inka and Lowe, Bernd and Bjorner, Jakob Bue and Fischer, Felix and Langs, Gernot and Voderholzer, Ulrich and Aita, Stephen A. and Bergemann, Niels and Brahler, Elmar and Rose, Matthias",Journal of clinical epidemiology,"OBJECTIVES: To provide a standardized metric for the assessment of depression severity to enable comparability among results of established depression measures. STUDY DESIGN AND SETTING: A common metric for 11 depression questionnaires was developed applying item response theory (IRT) methods. Data of 33,844 adults were used for secondary analysis including routine assessments of 23,817 in- and outpatients with mental and/or medical conditions (46% with depressive disorders) and a general population sample of 10,027 randomly selected participants from three representative German household surveys. RESULTS: A standardized metric for depression severity was defined by 143 items, and scores were normed to a general population mean of 50 (standard deviation = 10) for easy interpretability. It covers the entire range of depression severity assessed by established instruments. The metric allows comparisons among included measures. Large differences were found in their measurement precision and range, providing a rationale for instrument selection. Published scale-specific threshold scores of depression severity showed remarkable consistencies across different questionnaires. CONCLUSION: An IRT-based instrument-independent metric for depression severity enables direct comparisons among established measures. The ""common ruler"" simplifies the interpretation of depression assessment by identifying key thresholds for clinical and epidemiologic decision making and facilitates integrative psychometric research across studies, including meta-analysis.",2014,10.1016/j.jclinepi.2013.04.019,67,1,73-86,eng,1878-5921 0895-4356,Depression and Humans and Female and Male and Adult and Middle Aged and Psychometrics and Reproducibility of Results and Item response theory and Health outcome assessment and Severity of Illness Index and *Surveys and Questionnaires and Depression/*diagnosis and Patient-reported outcomes and Psychiatric Status Rating Scales/*standards and Item bank and Linking,NA,NA,2014/01//undefined,J Clin Epidemiol,NA,NA,NA,NA
Jonkman_2016_Joofclep,JOUR,Self-management interventions: Proposal and validation of a new operational definition,"Jonkman, Nini H. and Schuurmans, Marieke J. and Jaarsma, Tiny and Shortridge-Baggett, Lillie M. and Hoes, Arno W. and Trappenburg, Jaap C. A.",Journal of clinical epidemiology,"OBJECTIVES: Systematic reviews on complex interventions like self-management interventions often do not explicitly state an operational definition of the intervention studied, which may impact the review's conclusions. This study aimed to propose an operational definition of self-management interventions and determine its discriminative performance compared with other operational definitions. STUDY DESIGN AND SETTING: Systematic review of definitions of self-management interventions and consensus meetings with self-management research experts and practitioners. RESULTS: Self-management interventions were defined as interventions that aim to equip patients with skills to actively participate and take responsibility in the management of their chronic condition in order to function optimally through at least knowledge acquisition and a combination of at least two of the following: stimulation of independent sign/symptom monitoring, medication management, enhancing problem-solving and decision-making skills for medical treatment management, and changing their physical activity, dietary, and/or smoking behavior. This definition substantially reduced the number of selected studies (255 of 750). In two preliminary expert meetings (n = 6), the proposed definition was identifiable for self-management research experts and practitioners (80% and 60% agreement, respectively). CONCLUSION: Future systematic reviews must carefully consider the operational definition of the intervention studied because the definition influences the selection of studies on which conclusions and recommendations for clinical practice are based.",2016,10.1016/j.jclinepi.2016.08.001,80,NA,34-42,eng,1878-5921 0895-4356,Primary care and Humans and Chronic Disease and Chronic disease and Systematic review and Reproducibility of Results and *Review Literature as Topic and Complex interventions and Definition and Self Care/*classification/*methods and Self-management interventions,NA,NA,2016/12//undefined,J Clin Epidemiol,NA,NA,NA,NA
Razzaghi_2020_MMWMorandmorweerep,JOUR,"Estimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness - United States, 2018","Razzaghi, Hilda and Wang, Yan and Lu, Hua and Marshall, Katherine E. and Dowling, Nicole F. and Paz-Bailey, Gabriela and Twentyman, Evelyn R. and Peacock, Georgina and Greenlund, Kurt J.",MMWR. Morbidity and mortality weekly report,"Risk for severe coronavirus disease 2019 (COVID-19)-associated illness (illness requiring hospitalization, intensive care unit [ICU] admission, mechanical ventilation, or resulting in death) increases with increasing age as well as presence of underlying medical conditions that have shown strong and consistent evidence, including chronic obstructive pulmonary disease, cardiovascular disease, diabetes, chronic kidney disease, and obesity (1-4). Identifying and describing the prevalence of these conditions at the local level can help guide decision-making and efforts to prevent or control severe COVID-19-associated illness. Below state-level estimates, there is a lack of standardized publicly available data on underlying medical conditions that increase the risk for severe COVID-19-associated illness. A small area estimation approach was used to estimate county-level prevalence of selected conditions associated with severe COVID-19 disease among U.S. adults aged <e2><89><a5>18 years (5,6) using self-reported data from the 2018 Behavioral Risk Factor Surveillance System (BRFSS) and U.S. Census population data. The median prevalence of any underlying medical condition in residents among 3,142 counties in all 50 states and the District of Columbia (DC) was 47.2% (range = 22.0%-66.2%); counties with the highest prevalence were concentrated in the Southeast and Appalachian region. Whereas the estimated number of persons with any underlying medical condition was higher in population-dense metropolitan areas, overall prevalence was higher in rural nonmetropolitan areas. These data can provide important local-level information about the estimated number and proportion of persons with certain underlying medical conditions to help guide decisions regarding additional resource investment, and mitigation and prevention measures to slow the spread of COVID-19.",2020,10.15585/mmwr.mm6929a1,69,29,945-950,eng,1545-861X 0149-2195,"COVID-19 and Humans and Adult and Risk Assessment and Pandemics and Prevalence and Severity of Illness Index and United States/epidemiology and Coronavirus Infections/*epidemiology and Pneumonia, Viral/*epidemiology and Diabetes Mellitus/*epidemiology and Rural Population/statistics & numerical data and Obesity/*epidemiology and Urban Population/statistics & numerical data and Heart Diseases/*epidemiology and Pulmonary Disease, Chronic Obstructive/*epidemiology and Renal Insufficiency, Chronic/*epidemiology and Residence Characteristics/*statistics & numerical data",NA,NA,2020/07/24/,MMWR Morb Mortal Wkly Rep,NA,NA,NA,NA
Brundage_2020_Joofclep,JOUR,"Promoting effective use of patient-reported outcomes in clinical practice: themes from a ""Methods Tool kit"" paper series","Brundage, Michael D. and Wu, Albert W. and Rivera, Yonaira M. and Snyder, Claire",Journal of clinical epidemiology,"OBJECTIVES: ""PRO-cision Medicine,"" using patients' reports of their symptoms, functioning, and well-being to personalize their care, is becoming more prevalent. Patient-reported outcomes (PROs) are assessed using standardized, validated measures. Research shows that clinicians' and patients' understanding of what the PRO scores mean and how to act on them is often suboptimal. Methods to improve interpretation of PRO scores and action based on PRO results can promote more effective use of PROs in practice. STUDY DESIGN AND SETTING: A recent supplement to Medical Care describes various approaches to address challenges in interpreting and acting on PROs in practice and therefore serves as a ""PRO-cision Medicine Methods Tool kit."" This commentary provides an overview of the supplement and identifies cross-cutting themes guided by a theoretical framework. RESULTS: Six papers describe methods for interpreting PROs, and eight papers describe how different PRO systems address interpreting PRO scores and/or acting on PRO results. Based on the theoretical framework, cross-cutting themes are described in terms of (1) providing PRO information, (2) using PRO data, (3) screening for problems and monitoring for changes, and (4) changing management and behavior. CONCLUSIONS: The PRO-cision Medicine Methods Tool kit provides a useful resource for interpreting and acting on PRO scores to personalize patient care.",2020,10.1016/j.jclinepi.2020.01.022,122,NA,153-159,eng,1878-5921 0895-4356,"Cancer and Humans and Female and Male and Adult and Middle Aged and Aged and Aged, 80 and over and *Patient Reported Outcome Measures and *Clinical Decision-Making and *Guidelines as Topic and Precision Medicine/*standards and Patient-Centered Care/*standards and Patient-reported outcomes and Clinical encounter and Guidance and Interpretation and Symptom monitoring",NA,NA,2020/06//undefined,J Clin Epidemiol,NA,NA,NA,NA
Atkins_2011_Joofclep,JOUR,Assessing applicability when comparing medical interventions: AHRQ and the Effective Health Care Program,"Atkins, David and Chang, Stephanie M. and Gartlehner, Gerald and Buckley, David I. and Whitlock, Evelyn P. and Berliner, Elise and Matchar, David",Journal of clinical epidemiology,"OBJECTIVE: To describe a systematic approach for identifying, reporting, and synthesizing information to allow consistent and transparent consideration of the applicability of the evidence in a systematic review according to the Population, Intervention, Comparator, Outcome, Setting domains. STUDY DESIGN AND SETTING: Comparative effectiveness reviews need to consider whether available evidence is applicable to specific clinical or policy questions to be useful to decision makers. Authors reviewed the literature and developed guidance for the Effective Health Care program. RESULTS: Because applicability depends on the specific questions and needs of the users, it is difficult to devise a valid uniform scale for rating the overall applicability of individual studies or body of evidence. We recommend consulting stakeholders to identify the factors most relevant to applicability for their decisions. Applicability should be considered separately for benefits and harms. Observational studies can help determine whether trial populations and interventions are representative of ""real world"" practice. Reviewers should describe differences between available evidence and the ideally applicable evidence for the question being asked and offer a qualitative judgment about the importance and potential effect of those differences. CONCLUSION: Careful consideration of applicability may improve the usefulness of systematic reviews in informing practice and policy.",2011,10.1016/j.jclinepi.2010.11.021,64,11,1198-1207,eng,1878-5921 0895-4356,"United States and Humans and Female and Male and Adult and Middle Aged and Aged and Decision Making and Policy Making and Research Design and Review Literature as Topic and *Guidelines as Topic and Outcome Assessment, Health Care/methods and *Government Programs and *United States Agency for Healthcare Research and Quality and Comparative Effectiveness Research/*methods and Evidence-Based Medicine/*methods",NA,NA,2011/11//undefined,J Clin Epidemiol,NA,NA,NA,NA
Ekwueme_2019_MMWMorandmorweerep,JOUR,"Annual Out-of-Pocket Expenditures and Financial Hardship Among Cancer Survivors Aged 18-64 Years - United States, 2011-2016","Ekwueme, Donatus U. and Zhao, Jingxuan and Rim, Sun Hee and de Moor, Janet S. and Zheng, Zhiyuan and Khushalani, Jaya S. and Han, Xuesong and Kent, Erin E. and Yabroff, K. Robin",MMWR. Morbidity and mortality weekly report,"In the United States in 2019, an estimated 16.9 million persons are living after receiving a cancer diagnosis (1). These cancer survivors face many challenges, including functional limitations, serious psychological distress (2), and other lasting and late effects of cancer treatments. Because of the high cost of cancer therapy, many cancer survivors are more likely to face substantial out-of-pocket health care expenditures and financial hardship, compared with persons without a history of cancer (3,4). Out-of-pocket expenditures and financial hardship associated with cancer have been higher among survivors aged 18-64 years than they have been among older survivors (5). To estimate annual out-of-pocket expenditures and financial hardship among cancer survivors aged 18-64 years, compared with persons without a cancer history, CDC, the American Cancer Society, and the National Cancer Institute analyzed data from the 2011-2016 Medical Expenditure Panel Survey (MEPS).* The average annual out-of-pocket spending per person was significantly higher among cancer survivors ($1,000; 95% confidence interval [CI] = $886-$1,113) than among persons without a cancer history ($622; CI = $606-$639). Financial hardship was common; 25.3% of cancer survivors reported material hardship (e.g., problems paying medical bills), and 34.3% reported psychological hardship (e.g., worry about medical bills). These findings add to accumulating evidence documenting the financial difficulties of many cancer survivors. Mitigating the negative impact of cancer in the United States will require implementation of strategies aimed at alleviating the disproportionate financial hardship experienced by many survivors. These strategies include systematic screening for financial hardship at cancer diagnosis and throughout cancer care, integration of discussions about the potential for adverse financial consequences of treatments in shared treatment decision-making, and linkage of patients and survivors to available resources to ensure access to high-quality evidence-based care.",2019,10.15585/mmwr.mm6822a2,68,22,494-499,eng,1545-861X 0149-2195,United States and Humans and Female and Male and Adolescent and Adult and Middle Aged and Young Adult and Health Expenditures/*statistics & numerical data and *Cost of Illness and *Cancer Survivors/statistics & numerical data and Neoplasms/*economics/therapy,NA,NA,2019/06/07/,MMWR Morb Mortal Wkly Rep,NA,NA,NA,NA
Dionne_2011_Joofclep,JOUR,"Five questions predicted long-term, severe, back-related functional limitations: evidence from three large prospective studies","Dionne, Clermont E. and Le Sage, Natalie and Franche, Renee-Louise and Dorval, Michel and Bombardier, Claire and Deyo, Richard A.",Journal of clinical epidemiology,"OBJECTIVES: The objectives of the study were as follows: (1) to investigate whether the predictive validity of a previously developed back pain prediction rule could be improved; (2) to determine if the rule can be shortened without loss of predictive validity; (3) to compare the rule with the physician's judgment; (4) to assess, in a different population, its 2-year predictive validity; and (5) to evaluate the clinical applicability of the rule in a first-line care setting. STUDY DESIGN AND SETTING: One thousand two hundred and sixty-two participants were enrolled in the study (participation: 91%) before a medical consultation for nonspecific back pain in a large emergency room and were followed up for 2 years (follow-up: 92.5%). The effects of adding new items and deleting any one of the original items were evaluated. The predictions by the rule and the physicians were compared with the 2-year actual functional limitations (measured with the Roland-Morris Disability Questionnaire). RESULTS: Although the final prediction rule included only five items (feeling everything is an effort, trouble getting breath, hot/cold spells, numbness/tingling in parts of body, and pain in heart/chest), its predictive validity was greater than that of the original 17-item version and was superior to the physician's prediction. The rule was easily applied. CONCLUSION: A five-item clinical prediction rule of long-term back-related functional limitations could help first-line care physicians to concentrate the clinical attention on patients at higher risk.",2011,10.1016/j.jclinepi.2010.02.004,64,1,54-66,eng,1878-5921 0895-4356,Humans and Female and Male and Decision Making and Prospective Studies and Prognosis and Predictive Value of Tests and Pain Measurement and Disability Evaluation and Canada/epidemiology and Surveys and Questionnaires/*standards and Disabled Persons/statistics & numerical data and Back Pain/complications/*diagnosis/epidemiology,NA,NA,2011/01//undefined,J Clin Epidemiol,NA,NA,NA,NA
Tippins_2018_MMWMorandmorweerep,JOUR,"Vaccination Coverage Among Children Aged 2 Years - U.S. Affiliated Pacific Islands, April-October, 2016","Tippins, Ashley and Murthy, Neil and Meghani, Mehreen and Solsman, Amy and Apaisam, Carter and Basilius, Merlyn and Eckert, Maribeth and Judicpa, Peter and Masunu, Yolanda and Pistotnik, Kelsey and Pedro, Daisy and Sasamoto, Jeremy and Underwood, J. Michael",MMWR. Morbidity and mortality weekly report,"Vaccine-preventable diseases (VPDs) cause substantial morbidity and mortality in the United States Affiliated Pacific Islands (USAPI).* CDC collaborates with USAPI immunization programs to monitor vaccination coverage. In 2016, (<e2><80><a0>) USAPI immunization programs and CDC piloted a method for estimating up-to-date status among children aged 2 years using medical record abstraction to ascertain regional vaccination coverage. This was the first concurrent assessment of childhood vaccination coverage across five USAPI jurisdictions (American Samoa; Chuuk State, Federated States of Micronesia [FSM]; Commonwealth of the Northern Mariana Islands [CNMI]; Republic of the Marshall Islands [RMI]; and Republic of Palau).(<c2><a7>) Differences in vaccination coverage between main and outer islands(<c2><b6>) were assessed for two jurisdictions where data were adequate.** Series coverage in this report includes the following doses of vaccines: <e2><89><a5>4 doses of diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP); <e2><89><a5>3 doses of inactivated poliovirus vaccine (IPV); <e2><89><a5>1 dose of measles, mumps, and rubella vaccine (MMR); <e2><89><a5>3 doses of Haemophilus influenzae type B (Hib) vaccine; <e2><89><a5>3 doses of hepatitis B (HepB) vaccine; and <e2><89><a5>4 doses of pneumococcal conjugate vaccine (PCV); i.e., 4:3:1:3:3:4. Coverage with <e2><89><a5>3 doses of rotavirus vaccine was also assessed. Completion of the recommended series of each of these vaccines(<e2><80><a0><e2><80><a0>) was <90% in all jurisdictions except Palau. Coverage with the full recommended six-vaccine series (4:3:1:3:3:4) ranged from 19.5% (Chuuk) to 69.1% (Palau). In RMI and Chuuk, coverage was lower in the outer islands than in the main islands for most vaccines, with differences ranging from 0.9 to 66.8 percentage points. Medical record abstraction enabled rapid vaccination coverage assessment and timely dissemination of results to guide programmatic decision-making. Effectively monitoring vaccination coverage, coupled with implementation of data-driven interventions, is essential to maintain protection from VPD outbreaks in the region and the mainland United States.",2018,10.15585/mmwr.mm6720a3,67,20,579-584,eng,1545-861X 0149-2195,"Humans and Female and Male and Child, Preschool and Medical Records and Pacific Islands and Immunization Schedule and Diphtheria-Tetanus-Pertussis Vaccine/administration & dosage and Hepatitis B Vaccines/administration & dosage and Measles-Mumps-Rubella Vaccine/administration & dosage and Pneumococcal Vaccines/administration & dosage and Rotavirus Vaccines/administration & dosage and Vaccination Coverage/*statistics & numerical data and Vaccines/*administration & dosage",NA,NA,2018/05/25/,MMWR Morb Mortal Wkly Rep,NA,NA,NA,NA
Matanock_2019_MMWMorandmorweerep,JOUR,Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged 65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices,"Matanock, Almea and Lee, Grace and Gierke, Ryan and Kobayashi, Miwako and Leidner, Andrew and Pilishvili, Tamara",MMWR. Morbidity and mortality weekly report,"Two pneumococcal vaccines are currently licensed for use in adults in the United States: a 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Pfizer, Inc.]) and a 23-valent pneumococcal polysaccharide vaccine (PPSV23 [Pneumovax 23, Merck and Co., Inc.]). In 2014, the Advisory Committee on Immunization Practices (ACIP)* recommended routine use of PCV13 in series with PPSV23 for all adults aged <e2><89><a5>65 years based on demonstrated PCV13 safety and efficacy against PCV13-type pneumonia among adults aged <e2><89><a5>65 years (1). At that time, ACIP recognized that there would be a need to reevaluate this recommendation because it was anticipated that PCV13 use in children would continue to reduce disease burden among adults through reduced carriage and transmission of vaccine serotypes from vaccinated children (i.e., PCV13 indirect effects). On June 26, 2019, after having reviewed the evidence accrued during the preceding 3 years (https://www.cdc.gov/vaccines/acip/recs/grade/PCV13.html), ACIP voted to remove the recommendation for routine PCV13 use among adults aged <e2><89><a5>65 years and to recommend administration of PCV13 based on shared clinical decision-making for adults aged <e2><89><a5>65 years who do not have an immunocompromising condition,(<e2><80><a0>) cerebrospinal fluid (CSF) leak, or cochlear implant, and who have not previously received PCV13. ACIP recognized that some adults aged <e2><89><a5>65 years are potentially at increased risk for exposure to PCV13 serotypes, such as persons residing in nursing homes or other long-term care facilities and persons residing in settings with low pediatric PCV13 uptake or traveling to settings with no pediatric PCV13 program, and might attain higher than average benefit from PCV13 vaccination. When patients and vaccine providers(<c2><a7>) engage in shared clinical decision-making for PCV13 use to determine whether PCV13 is right for a particular person, considerations might include both the person's risk for exposure to PCV13 serotypes and their risk for developing pneumococcal disease as a result of underlying medical conditions. All adults aged <e2><89><a5>65 years should continue to receive 1 dose of PPSV23. If the decision is made to administer PCV13, it should be given at least 1 year before PPSV23. ACIP continues to recommend PCV13 in series with PPSV23 for adults aged <e2><89><a5>19 years with an immunocompromising condition, CSF leak, or cochlear implant (2).",2019,10.15585/mmwr.mm6846a5,68,46,1069-1075,eng,1545-861X 0149-2195,"United States and Humans and Aged and Advisory Committees and Centers for Disease Control and Prevention, U.S. and Pneumococcal Vaccines/*administration & dosage",NA,NA,2019/11/22/,MMWR Morb Mortal Wkly Rep,NA,NA,NA,NA
